volume 56 pages 116612

Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs

Publication typeJournal Article
Publication date2022-02-01
scimago Q2
wos Q1
SJR0.608
CiteScore6.7
Impact factor3.0
ISSN09680896, 14643391
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Pharmaceutical Science
Clinical Biochemistry
Molecular Medicine
Abstract
Continuing on our antiviral drug discovery research, we intended to diversify our lead anti-HIV-1 inhibitor by non-classical isosteric replacement of amide to 1,2,4-oxadiazoles. The resulting molecules isoxazole-1,2,4-oxadiazole analogs were synthesized using mild bases in ethanol under microwave irradiation. The anti-HIV potential was checked in human CD4+ reporter cell lines, TZM-bl and CEM-GFP, at the highest non-cytotoxic concentration (HNC), demonstrating that 3-((3-(p-tolyl)isoxazol-5-yl)methyl)-1,2,4-oxadiazole and 3-((3-(4-chlorophenyl)isoxazol-5-yl)methyl)-1,2,4-oxadiazole inhibit HIV-1 replication significantly and could be considered as a new lead candidate against HIV-1.
Found 
Found 

Top-30

Journals

1
2
Bioorganic and Medicinal Chemistry
2 publications, 11.76%
Molecules
2 publications, 11.76%
RSC Advances
1 publication, 5.88%
Journal of Enzyme Inhibition and Medicinal Chemistry
1 publication, 5.88%
Russian Journal of General Chemistry
1 publication, 5.88%
Synthetic Communications
1 publication, 5.88%
Computational Biology and Chemistry
1 publication, 5.88%
Journal of Molecular Structure
1 publication, 5.88%
Journal of the Chinese Chemical Society
1 publication, 5.88%
Synthesis
1 publication, 5.88%
Molecular Diversity
1 publication, 5.88%
ACS Omega
1 publication, 5.88%
Bioorganic Chemistry
1 publication, 5.88%
Inorganica Chimica Acta
1 publication, 5.88%
Russian Chemical Reviews
1 publication, 5.88%
1
2

Publishers

1
2
3
4
5
6
Elsevier
6 publications, 35.29%
Taylor & Francis
2 publications, 11.76%
MDPI
2 publications, 11.76%
Royal Society of Chemistry (RSC)
1 publication, 5.88%
Pleiades Publishing
1 publication, 5.88%
Wiley
1 publication, 5.88%
Georg Thieme Verlag KG
1 publication, 5.88%
Springer Nature
1 publication, 5.88%
American Chemical Society (ACS)
1 publication, 5.88%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 5.88%
1
2
3
4
5
6
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
17
Share
Cite this
GOST |
Cite this
GOST Copy
Kumar Kushwaha P. et al. Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs // Bioorganic and Medicinal Chemistry. 2022. Vol. 56. p. 116612.
GOST all authors (up to 50) Copy
Kumar Kushwaha P., Srivastava K. V., Kumari N., Kumar R., Mitra D., Sharon A. Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs // Bioorganic and Medicinal Chemistry. 2022. Vol. 56. p. 116612.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.bmc.2022.116612
UR - https://doi.org/10.1016/j.bmc.2022.116612
TI - Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs
T2 - Bioorganic and Medicinal Chemistry
AU - Kumar Kushwaha, Prem
AU - Srivastava, Kumar Vaibhav
AU - Kumari, Neha
AU - Kumar, Rajan
AU - Mitra, Debashis
AU - Sharon, Ashoke
PY - 2022
DA - 2022/02/01
PB - Elsevier
SP - 116612
VL - 56
PMID - 35026631
SN - 0968-0896
SN - 1464-3391
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Kumar Kushwaha,
author = {Prem Kumar Kushwaha and Kumar Vaibhav Srivastava and Neha Kumari and Rajan Kumar and Debashis Mitra and Ashoke Sharon},
title = {Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs},
journal = {Bioorganic and Medicinal Chemistry},
year = {2022},
volume = {56},
publisher = {Elsevier},
month = {feb},
url = {https://doi.org/10.1016/j.bmc.2022.116612},
pages = {116612},
doi = {10.1016/j.bmc.2022.116612}
}
Profiles